These statements concern, and these risks and uncertainties include, among others, the nature, timing, and possible success and therapeutic applications of products marketed or otherwise commercialized by Regeneron and/or its collaborators or licensees (collectively, Regenerons Products) and product candidates being developed by Regeneron and/or its collaborators or licensees (collectively, Regenerons Product Candidates) and research and clinical programs now underway or planned, including without limitation Regenerons clinical program investigating novel combinations of semaglutide (GLP-1 receptor agonist) and high- or low-dose trevogrumab (anti-GDF8 /anti-myostatin) with or without garetosmab (anti-activin A) for the treatment of obesity as discussed in this press release
Noticing changes in your appetite is trickier than tracking weight, but it is just as important
Edinburgh: Elsevier, 2017:205-14
Whether youre easing into a new medication or looking for a more pleasant way to meet your nutrition goals, these shakes can be a game changer
They can provide safe and effective options tailored to help you reach your health goal